Brief: SynAct To Get SEK 17.7 Mln After Conversion Of Warrants
July 16 (Reuters) - Synact Pharma AB SYNACT.ST: SAID ON TUESDAY HCM TO EXECUTE ON CONVERSION OF 1,000,000 OF WARRANTS, GENERATING SEK 17.7 MLN TO SYNACT Source text for Workspace: nMFN4g8Wgc Further company coverage: SYNACT.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on SynAct Pharma AB
See all newsSweden's SynAct Pharma Q3 net loss narrows as expenses fall
Brief: SynAct Pharma Q3 Net Income SEK -32.177 Million
Brief: SynAct Pharma Signs First Commercial Partnership For Resomelagon
Brief: WHO Names Resomelagon Among Key Dengue Drug Candidates
Brief: SynAct Pharma Says Advance Analysis Supports Phase 3 Development